UK markets open in 2 hours 51 minutes

DATRON AG (DAR.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
9.550.00 (0.00%)
At close: 05:36PM CEST
Full screen
Previous close9.55
Open9.55
Bid9.40 x 50000
Ask9.70 x 135400
Day's range9.55 - 9.55
52-week range9.25 - 13.20
Volume300
Avg. volume928
Market cap38.05M
Beta (5Y monthly)N/A
PE ratio (TTM)13.08
EPS (TTM)N/A
Earnings date02 Nov 2022 - 07 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.40
  • Business Wire

    GenSight Biologics: Annual General Meeting on May 25, 2022

    PARIS, May 04, 2022--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (Paris:SIGHT), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced that it will hold its Annual General Meeting on May 25, 2022, at 9:00 am CEST at the Company’s headquarters, 74 rue du Faubourg Saint-Antoine, 75012 Paris, France (*).

  • Business Wire

    GenSight Biologics Granted Six-Month Extension in LUMEVOQ® European Regulatory Review

    PARIS, April 14, 2022--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma Company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that the Committee for Advanced Therapies (CAT) of the European Medicines Agency (EMA) has granted the Company a six-month extension for submitting its responses to the Day 120 questions in the regulator